Top

Published in:

01-03-2016 | Case Report

Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment

Authors: Akihiro Shirakabe, Masamichi Takano, Masanori Yamamoto, Osamu Kurihara, Nobuaki Kobayashi, Masato Matsushita, Masafumi Tsurumi, Hirotake Okazaki, Noritake Hata, Wataru Shimizu

Published in: Heart and Vessels | Issue 3/2016

Abstract

This case report describes a patient who underwent implantation of a bare-metal stent (BMS) for the treatment of everolimus-eluting stent (EES) restenosis caused by chronic stent recoil, and the BMS successfully escaped from duplicate restenosis and target lesion revascularization (TLR).

Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group (2002) Randomized study with the Sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780CrossRef

Yamawaki M, Onuma Y, Nakano M, Muramatsu T, Nakatani S, Ishibashi Y, Ishimori H, Hirano K, Ito Y, Tsukahara R, Muramatsu T (2014) Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound. Heart Vessels. doi:10.1007/s00380-014-0545-0

Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, Hamm C, Otto-Terlouw PC (2005) A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention 1:58–65PubMed

Applegate RJ, Yaqub M, Hermiller JB, Sood P, Yu S, Doostzadeh J, Williams JE, Farhat N, Caputo R, Lansky AJ, Cutlip DE, Sudhir K, Stone GW (2011) Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial). Am J Cardiol 107:833–840CrossRefPubMed

Dörr O, Liebetrau C, Wiebe J, Hecker F, Rixe J, Möllmann H, Hamm C, Nef H (2014) Bioresorbable scaffolds for the treatment of in-stent restenosis. Heart Vessels. doi:10.1007/s00380-013-0464-5

Lemos PA, van Mieghem CA, Arampatzis CA, Hoye A, Ong AT, McFadden E, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW (2004) Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation 109:2500–2502CrossRefPubMed

Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 123:2954–2963CrossRefPubMed

van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, de Feijter PJ, Serruys PW, van der Giessen WJ (2007) Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 28:974–979

Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA (2007) Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 70:515–523CrossRefPubMed

10.

Haude M, Erbel R, Issa H, Meyer J (1993) Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol 21:26–34CrossRefPubMed

11.

Koo BK, Waseda K, Ako J, Hasegawa T, Shimohama T, Nakatani D, Otake H, Yamasaki M, Sakurai R, Tsujino I, Honda Y, Fitzgerald PJ (2010) Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents. Int J Cardiol 144:132–134CrossRefPubMed

12.

Ratib K, Doshi SN, Townend JN (2005) Double-stenting of an ostial left main-stem lesion for elastic recoil. Int J Cardiol 102:357–358CrossRefPubMed

13.

Tsunoda T, Nakamura M, Wada M, Ito N, Kitagawa Y, Shiba M, Yajima S, Iijima R, Nakajima R, Yamamoto M, Takagi T, Yoshitama T, Anzai H, Nishida T, Yamaguchi T (2004) Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis 15:39–44CrossRefPubMed

14.

Barlis P, Kaplan S, Dimopoulos K, Ferrante G, Di Mario C (2008) Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease. Cardiology 111:270–276CrossRefPubMed

15.

He Y, Maehara A, Mintz GS, Bharaj H, Castellanos C, Kesanakurthy S, Wu X, Guo N, Choi SY, Leon MB, Stone GW, Mehran R, Rabbani LE, Moses JW (2010) Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. Am J Cardiol 105:1272–1275CrossRefPubMed

16.

Ako J, Bonneau HN, Honda Y, Fitzgerald PJ (2007) Design criteria for the ideal drug-eluting stent. Am J Cardiol 100:3M–9MCrossRefPubMed

17.

Williams PD, Appleby CE, Chowdhary S, Fraser DG (2011) Double stenting: a method for treating acute stent recoil and luminal filling defects. EuroIntervention 6:846–853CrossRefPubMed

18.

Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M (2011) Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv 4:149–154CrossRefPubMed

Title: Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment
Authors: Akihiro Shirakabe
Masamichi Takano
Masanori Yamamoto
Osamu Kurihara
Nobuaki Kobayashi
Masato Matsushita
Masafumi Tsurumi
Hirotake Okazaki
Noritake Hata
Wataru Shimizu
Publication date: 01-03-2016
Publisher: Springer Japan
Published in: Heart and Vessels / Issue 3/2016
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-014-0588-2

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Preventable effects of bare-metal stent on restenosis after everolimus-eluting stent deployment

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Comparison of new adenosine diphosphate receptor antagonists with clopidogrel in patients with coronary artery disease: a meta-analysis

Assessment of risk factors and left ventricular function in patients with slow coronary flow

Clinical characteristics and intravascular ultrasound findings of culprit lesions in elderly patients with acute coronary syndrome

Phrenic nerve protection via packing of gauze into the pericardial space during ablation of cristal atrial tachycardia in a child

Sources of variation in assessing left atrial functions by 2D speckle-tracking echocardiography

Effect of serum uric acid on the positive predictive value of dobutamine stress echocardiography

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page